{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:29:03Z","timestamp":1791577743648,"version":"4.3.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","award":["9127"],"award-info":[{"award-number":["9127"]}],"id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008920","name":"University of Saskatchewan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jac\/dkx333","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T19:10:09Z","timestamp":1504552209000},"page":"118-125","source":"Crossref","is-referenced-by-count":18,"title":["High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?"],"prefix":"10.1093","volume":"73","author":[{"given":"Sidharath D","family":"Thakur","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"},{"name":"Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N","family":"Levett","sequence":"additional","affiliation":[{"name":"Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B","family":"Horsman","sequence":"additional","affiliation":[{"name":"Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne R","family":"Dillon","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"},{"name":"Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"key":"key\n\t\t\t\t20180328171745_dkx333-B1","doi-asserted-by":"crossref","first-page":"e0143304.","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B2","first-page":"1","article-title":"Antibiotic resistance in Neisseria gonorrhoeae isolates: will infections be untreatable in the future?","volume":"35","author":"Dillon","year":"2015","journal-title":"Culture (Oxoid)"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B4","doi-asserted-by":"crossref","first-page":"364.","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B5","author":"Public Health Agency of Canada","year":"2014"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B6","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B7","doi-asserted-by":"crossref","first-page":"pii: e00966-16","DOI":"10.1128\/genomeA.00966-16","article-title":"Complete genome sequences of Neisseria gonorrhoeae with coresistance to first-line antimicrobials","volume":"4","author":"Bharat","year":"2016","journal-title":"Genome Announc"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B9","volume-title":"Notifiable Diseases On-line","author":"Public Health Agency of Canada","year":"2016"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B10","volume-title":"Report on Sexually Transmitted Infections in Canada: 2012. 2. Gonorrhea (Neisseria gonorrhoeae)","author":"Public Health Agency of Canada","year":"2015"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B11","author":"Dillon","year":"1990"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B12","volume-title":"Canadian Guidelines on Sexually Transmitted Infections, 2006 Edition","author":"Public Health Agency of Canada","year":"2006"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.1.4.415","article-title":"Historical perspectives and identification of Neisseria and related species","volume":"1","author":"Knapp","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B14","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B15","first-page":"355","article-title":"Surveillance of antimicrobial resistance of Neisseria gonorrhoeae in the WHO Western Pacific Region, 1992\u20134","volume":"73","author":"WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme","year":"1997","journal-title":"Genitourin Med"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","author":"Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B17","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1128\/JCM.02303-15","article-title":"Quality assurance for antimicrobial susceptibility testing of Neisseria gonorrhoeae in Canada, 2003 to 2012","volume":"53","author":"Sawatzky","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance - the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B19","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/OLQ.0b013e31822c664f","article-title":"Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009","volume":"38","author":"Martin","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1503\/cmaj.080222","article-title":"Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario","volume":"180","author":"Ota","year":"2009","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/OLQ.0b013e3181aad9df","article-title":"Antimicrobial resistance in gonorrhea: the influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001-2007","volume":"36","author":"Plitt","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B25","author":"Public Health Agency of Canada","year":"2016"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3201\/eid2201.151247","article-title":"Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in Neisseria gonorrhoeae, Canada","volume":"22","author":"Martin","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B27","author":"Cole","year":"2016"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkn235","article-title":"Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland","volume":"62","author":"Palmer","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkp188","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales","volume":"64","author":"Chisholm","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jac\/dkp118","article-title":"Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy","volume":"63","author":"Starnino","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/AAC.01506-09","article-title":"New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae","volume":"54","author":"Galarza","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B32","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/jac\/dkv106","article-title":"Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland","volume":"70","author":"Lynagh","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/JCM.03195-15","article-title":"Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014","volume":"54","author":"Demczuk","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B34","doi-asserted-by":"crossref","first-page":"366.","DOI":"10.1186\/s12879-017-2472-z","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance","volume":"17","author":"Jiang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B35","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.33321\/cdi.2017.41.14","article-title":"Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016","volume":"41","author":"Lahra","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B36","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix485","article-title":"Cluster of Neisseria gonorrhoeae isolates with high-level azithromycin resistance and decreased ceftriaxone susceptibility, Hawaii, 2016","author":"Katz","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B37","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B38","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/jac\/dku118","article-title":"Treatment failure with 2\u2009g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae","volume":"69","author":"Morita-Ishihara","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/OLQ.0000000000000265","article-title":"Failure of azithromycin 2.0\u2009g in the treatment of gonococcal urethritis caused by high-level resistance in California","volume":"42","author":"Gose","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B40","author":"Public Health Agency of Canada","year":"2013"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/OLQ.0000000000000279","article-title":"High prevalence of azithromycin-resistant Neisseria gonorrhoeae isolates with a multidrug resistance phenotype in Fukuoka, Japan","volume":"42","author":"Tanaka","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B42","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.17269\/rcsp.106.4792","article-title":"Demographic and behavioural characteristics predict bacterial STI reinfection and coinfection among a cross-sectional sample of laboratory-confirmed gonorrhea cases in a local health region from Saskatchewan, Canada","volume":"106","author":"Trecker","year":"2015","journal-title":"Can J Public Health"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B43","first-page":"257","article-title":"Activity of eight antimicrobial agents in vitro against N. gonorrhoeae","volume":"51","author":"Stolz","year":"1975","journal-title":". Br J Vener Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(81)91227-7","article-title":"Spectinomycin-resistant penicillinase producing Neisseria gonorrhoeae","volume":"ii","author":"Ashford","year":"1981","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae","volume":"317","author":"Boslego","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B46","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/bmj.284.6329.1604","article-title":"Emergence of resistance after spectinomycin treatment for gonorrhoea due to \u03b2-lactamase producing strain of Neisseria gonorrhoeae","volume":"284","author":"Easmon","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B47","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/bmj.287.6408.1827","article-title":"Spectinomycin resistant gonococci","volume":"287","author":"Ison","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B48","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw864","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system","volume":"64","author":"Allan-Blitz","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European Surveillance of Sexually Transmitted Infections Network. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"86","author":"Cole","year":"2010","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B50","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.33321\/cdi.2015.39.39","article-title":". Australian Gonococcal Surveillance Programme annual report, 2014","volume":"39","author":"Lahra","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.33321\/cdi.2011.35.1","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2009","volume":"35","author":"WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B52","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1093\/jac\/dkw291","article-title":"Real-time PCR detection of Neisseria gonorrhoeae susceptibility to penicillin","volume":"71","author":"Buckley","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B53","doi-asserted-by":"crossref","first-page":"e0133202.","DOI":"10.1371\/journal.pone.0133202","article-title":"Exploring the benefits of molecular testing for gonorrhea antibiotic resistance surveillance in remote settings","volume":"10","author":"Hui","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B54","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328171745_dkx333-B55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","article-title":"Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?","volume":"91","author":"Lewis","year":"2015","journal-title":"Sex Transm Infect"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/1\/118\/22755556\/dkx333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:18:30Z","timestamp":1750864710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/1\/118\/4259081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,9,27]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx333","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,9,27]]}}}